Theme: Transforming the Future of Cytopathology & Histopathology

Cytopathology 2017
Past Report of Cytopathology 2016

Cytopathology 2017

Cytopathology 2017 invites scholars, researchers, academicians, students and corporate entities across the globe to join at the 3rd International Conference on Cytopathology & Histopathology (Cytopathology-2017) to have a meaningful discussion with scholars during June 26-28, 2017 in Philadelphia, USA. The conference focuses on “Transforming Future of Cytopathology & Histopathology”.

 

 

Cytopathology 2017 anticipates participants all around the globe with thought provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

After Successful completion of Cytopathology 2016, Conference Series LLC welcomes all to join the exclusive event 3rd International Conference on Cytopathology & Histopathology, Philadelphia, USA and showcase the recent research in the tremendous field of Cytopathology-Histopathology among the experts.

Students are warmly welcome to attend or to present their research work as Poster presenter and Young Researcher forum in this prestigious profile Cytopathologists & Histopathologists.

Who is attending?

  • Deans/Chairs, Vice Deans & Vice Presidents of Medical Institutions and Hospitals
  • Professors and students from academia who are in the field of research, Medical and clinical research.
  • Physicians, Business delegates, Directors / Managers & Business Intelligence Experts, Departmental Managers.

Benefits of Attending the Conference

  • The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows, Certificate Accreditation from the Organizing Committee of presentation/ participation.
  • Accepted Abstracts will be published in the respective journals and will be labeled with a Digital Object Identification Number (DOI) provided by Cross Ref (Free abstract publishing).
  • Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your profile and Research.
  • Best Poster and Young Researcher Award.

Supporting Journals:

Contact Person:

Robert Johnson

Program Manager | Cytopathology 2017

Phone:1-888-843-8169

Email: cytopathology@conferenceseries.net

 

Cytopathology Congress one of the World's best platform on Pathology events will enable to put forth the holistic scientific approach to validating existing and development of Cytopathologic and Histopathologic techniques as to better understanding of diseases and diagnosis. Cytopathology conference is set to witness an exhilarating sessions in scientific program which will focus on latest innovations in Cancer Cytopathology, Clinical & Molecular Cytopathology, Stem Cell Therapy & Anatomical Pathology, Diagnostic & Comprehensive Cytopathology, General Cytopathology & Immunocytochemistry, Cytopathology & Disease diagnosis, Forensic Cytopathology, Genome Expression Profiling, Gene therapy, Bacterial & Microbial pathology Infection control, Veterinary Cytopathology.

Cytopathology Meeting will be the platform for business delegates, B2B meetings, poster presentations, Cytopathology workshops, Cytopathology symposia and much more. Past conference of Cytopathology meeting in 2015 & 2016 has grounded the best possible researchers in the field of Cytopathology & Histopathology from diverse scientific disciplines and opened the channels for research funding opportunities and collaborations, and so will be upcoming.

Track 1Cancer Cytopathology

Cytopathology usually used to aid in the diagnosis of cancer, but also helps in the diagnosis of certain infectious diseases and other inflammatory conditions. Cancer Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. Cytopathologic tests are sometimes called smear tests because the samples may be smeared across a glass microscope slide for subsequent staining and microscopic examination. Gallbladder cancer is a relatively uncommon cancer and can be cure by fine needle aspiration material. However, cytology samples may be prepared in other ways, including cytocentrifugation. Different types of smear tests may also be used for cancer diagnosis. In this sense, it is termed a cytological smear. Epidemiology of Breast Cancer is the most commonly diagnosed cancer among women, with approximately 182,000 women diagnosed with breast cancer annually in the United States, accounting for approximately 26% of all incident cancers among women. Each year, 40,000 women die of breast cancer, making it the second-leading cause of cancer deaths among American women after lung cancer. The lifetime risk of dying of breast cancer is approximately 3.4%.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference, May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 2Histopathology

Histopathology is the science or study dealing with the cytological and histologic structure of the abnormal or diseased tissue. Although it refers to the microscopic examination of tissue in order to study the manifestations of the disease. The study of tissues is called Tissue histology and is important to the understanding of how the human body is able to function as a unit. in clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue fragments. Immunohistochemistry (IHC) refers to the process of detecting antigens (e.g. proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.

Histology, There are four basic types of tissues: muscle tissue, nervous tissue, connective tissue, and epithelial tissue. All tissue types are subtypes of these four basic tissue types (for example, blood cells are classified as connective tissue, since they generally originate inside bone marrow).

Histopathology, the microscopic study of diseased tissue, is an important tool in anatomical pathology since accurate diagnosis of cancer and other diseases usually requires histopathological samples.

Relevant Conferences:

Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 3Diagnostic Cytopathology

Diagnostic Cytopathology Essentials is a succinct yet comprehensive guide to diagnosis in both non-gynecological and gynecological cytology. It provides quick answers to diagnostic problems in the cytological interpretation and recognition of a wide range of disease entities. Diagnosis of Cancer is nearly always diagnosed by an expert who has looked at cell or tissue samples under a microscope. In some cases, tests done on the cells’ proteins, DNA, and RNA can help tell doctors if there’s cancer. These test results are very important when choosing the best treatment options. Fine needle aspiration cytology is an inexpensive, a traumatic technique for the diagnosis of disease sites. It illustrates how it may be applied to the management of tumors throughout the body. The limitations of the method, the dangers of false positive reports, and the inevitability of false negative diagnoses are emphasized. In a clinical context the method has much to offer by saving patients from inappropriate operations and investigations and allowing surgeons to plan quickly and more rationally. It is an economically valuable technique and deserves greater recognition. Esophagus cancers are usually found because of signs or symptoms a person is having. If esophagus cancer is suspected, exams and tests will be needed to confirm the diagnosis. If cancer is found, further tests will be done to help determine the extent (stage) of the cancer.

Relevant Conferences:

Clinical Pathology Conference, Sept 26-28, 2016 Toronto, Canada; Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Conference, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA;; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 5Clinical & Molecular Cytopathology

Molecular Cytopathology is an emerging discipline within Cytopathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology and molecular pathology. Cervical cancer is the third most common type of cancer among women worldwide. The infection and persistence of human papillomavirus (HPV) are the essential conditions for this type of disease. However, only HPV infection is not enough for cervical pathogenesis are necessary cofactors and activation of intracellular and extracellular mechanisms to start.

In the conventional Pap smear, the physician collecting the cells smears them on a microscope slide and applies a fixative. In general, the slide is sent to a laboratory for evaluation. The studies include Liquid-based monolayer cytology and Human papillomavirus testing. Diagnostic molecular pathology: Recent revolutionary progress in human genomics is reshaping our approach to therapy and diagnosis

 

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Histology Conference, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 6Exfoliative Cytopathology

Exfoliative Cytopathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical pathology involves gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists.

Relevant Conferences

Euro Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 7General Cytopathology & Immunocytochemistry

Cytology, also known as cytotechnology or cytopathology, is a specialized field in medical lab technology in which technicians examine cells for signs of cancer. Fine Needle Aspiration (FNA) is a technique used to improve the clinical management of thyroid lesions, Thyroid Cytopathology. The introduction of a standardized and reproducible terminology system for diagnosis of a particular condition should reduce the need for unnecessary investigations and operations. Standardization of terminology is expected to improve patient safety and reduce risk to patients as any positive result will be identified and acted upon quickly. Immunocytochemistry (ICC) is a common laboratory technique that is used to anatomically visualize the localization of a specific protein or antigen in cells by use of a specific primary antibody that binds to it. The primary antibody allows visualization of the protein under a fluorescence microscope when it is bound by a secondary antibody that has a conjugated fluorophore.

The American Thyroid Association (ATA) is an international membership medical society with over 1,700 members from 43 countries around the world.  The ATA delivers its mission -of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health. Likewise, Akrimax Pharmaceuticals, LLC, Bayer Healthcare/Onyx Pharmaceuticals, CBLPath, Endocrine Education, Inc. and much more are there in the tip of the growth of Cytopathology era.

Relevant Conferences:

Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK;; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 8Cervical Cytopathology

Cervical cytology became the standard screening test for cervical cancer and premalignant cervical lesions. Cytologic examinations may be performed on body fluids (examples are blood, urine, and cerebrospinal fluid) or on material that is aspirated (drawn out via suction into a syringe) of the body. Cytology also can involve examinations of preparations that are scraped or washed (irrigated with a sterile solution) from specific areas of the body. For example, a common example of diagnostic cytology is the evaluation of cervical smears (referred to as the Papanicolaou test or Pap smear).

There are several methods to screen for cervical cancer. The Pap test (also known as Pap smear or conventional cytology) and liquid-based cytology are widely used throughout the world and have been credited with greatly reducing the number of cases and mortality from cervical cancer in the developed world. Cytology-based tests have not been as effective in developing countries, leading to an investigation of cervical screening approaches more suited to low-resource settings such as visual inspection with acetic acid or HPV DNA testing.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 9Cytopathology & Disease diagnosis

 Cytology is a key component in diagnosis and screening of diseases such as cancer. Cytology disease diagnosis assesses single cells and clusters of cells from sources such as malignant effusions and peripheral blood. Effusions are fluids that leak from blood and lymph vessels and aggregate in tissues and cavities within the body. This is a common problem in cancer patients and can be a reservoir of malignant cells. However, the total number of cells in effusions is small in comparison to the volumes of fluids that are produced. Therefore, in order to collect these cells for evaluation, they must be concentrated. Liver disease diagnosis can often be difficult to diagnose because its symptoms can be vague and easily confused with other health problems. In some cases, a person may have no symptoms at all but the liver may already have suffered significant damage.

Gynecologic cytology, also gynecologic cytopathology, is a field of pathology concerned with the investigation of disorders of the female genital tract. The most common investigation in this field is the Pap test, which is used to screen for potentially precancerous lesions of the cervix. Cytology can also be used to investigate disorders of the ovaries, uterus, vagina and vulva.

A survey was conducted among 130 New York State (NYS) registered cytology laboratories to better understand current and future changes in the practice of cytology, changes in the cytotechnologist (CT) scope of practice, and the future need for CTs. A 51.5% (67/130) response rate was obtained. Trends for gynecologic case volume varied across facility types.  Non-gynecologic volume is growing primarily in hospitals and large medical center laboratories and private laboratories; the fine-needle aspiration volume is growing in hospital and large medical center laboratories. One-third of responding laboratories anticipates a continued demand for CTs within the next 3 years owing to impending retirements. Few laboratories also report the gradual adoption of molecular testing with CTs directly involved. Because 60% (3/5) of NYS CT training programs have closed since 2008, the 2 remaining programs are a valuable key staffing resource for CTs. Continued viability of these programs is essential to provide the necessary training and staffing of NYS laboratories for cytopathology practice.

Relevant Conferences:

Histology Meeting, August 11-12, 2016 New Orleans, USA; Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Molecular Pathology Conferences, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 10Veterinary Cytopathology

Veterinary Cytopathology is concerned with the diagnosis of disease based on the gross examination, microscopic, and molecular examination of organs, tissues, and whole bodies (necropsy). Veterinary pathologists are doctors of veterinary medicine who specialize in the diagnosis of diseases through the examination of animal tissue and body fluids. Other than the diagnosis of disease in food-producing animals, companion animals, zoo animals and wildlife, veterinary pathologists also have an important role in drug discovery and safety as well as scientific research. Veterinary Clinical Sciences is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids such as blood, urine or cavitary effusions, or tissue aspirates using the tools of chemistry, microbiology, hematology and molecular pathology.

The Treatment of Veterinary Diseases of veterinary diseases is possible with the Veterinary clinical science with the help of the diagnosis pattern. Among the four major geographies namely North America, Europe, Asia-Pacific and Rest of the world, European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. These two regions collectively account for more than 70% of the global veterinary vaccine market revenue.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 11Fine-needle aspiration Cytology

Fine-needle aspiration biopsy (FNAB, FNA or NAB), or fine-needle aspiration cytology (FNAC), is a diagnostic procedure used to investigate superficial (just under the skin) lumps or masses. In this technique, a thin, hollow needle is inserted into the mass for sampling of cells that, after being stained, will be examined under a microscope. There could be cytology exam of aspirate (cell specimen evaluation, FNAC) or histological (biopsy - tissue specimen evaluation, FNAB). Gene expression profiling is the measurement of the activity (the expression) of thousands of genes at once, to create a global picture of cellular function. These profiles can, for example, distinguish between cells that are actively dividing, or show how the cells react to a particular treatment. Many experiments of this sort measure an entire genome simultaneously, that is, every gene present in a particular cell. Fine-needle aspiration biopsies are very safe, minor surgical procedures. Often, a major surgical (excisional or open) biopsy can be avoided by performing a needle aspiration biopsy instead. In 1981, the first fine-needle aspiration biopsy in the United States was done at Maimonides Medical Center, eliminating the need for surgery and hospitalization. Today, this procedure is widely used in the diagnosis of cancer and inflammatory conditions. Gene expression the appearance in a phenotype of a characteristic or effect attributed to a particular gene. The process by which possession of a gene leads to the appearance of the phenotype of the corresponding character.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Conference, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 12Cytopathology Case Reports

Cytopathology is the examination of cells from the body under the microscope to identify the signs and characteristics of the disease. Cytopathology is often loosely called "cytology," a word that simply means the study of cells.

A cytopathology report tells us whether the cells studied contain signs of disease. Cells examined for cytopathology can come from fluids extracted from body cavities - e.g. urine, sputum (spit), or fluids accumulating inside the chest or abdomen. Cells can also be extracted by inserting needles into lumps or diseased areas or tissues - called fine needle aspiration cytology (FNAC).

Laboratories may include recommendations as part of the Gynaecology Case reports.  These may include a suggestion to the clinician for repeat cytology after a certain time interval or after treatment, or for tissue studies to further evaluate epithelial cell abnormalities.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 13Urine Cytology

Cytology is the examination of cells from the body under a microscope. In a urine cytology exam, a doctor looks at cells collected from a urine specimen, to see how they look and function. The test commonly checks for infection, inflammatory disease of the urinary tract, cancer, or precancerous conditions. Urine cytology is better at finding larger and more aggressive cancers than small, slow growing cancers.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 14Stem Cell Therapy & Anatomical Pathology

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Cytopathology surgical autopsy service serves multiple important functions. In addition to routine autopsy reports, this section provides sources of material for many research activities, including retrospective studies of various diseases, case reports, comparative tissue studies and studies of various physiologic functions related to a malignant disease. The service provides tissue for virologic, biochemical, molecular and electron microscopic studies.

Anatomic pathology (U.S.) is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.

The acute ischemic stroke diagnosis and treatment market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America represented the largest regional market for acute ischemic stroke primarily due to the increase in ischemic stroke surgeries and introduction of technologically advanced medical devices and products. For instance, American Heart Association stated that stroke is considered as the third leading cause of death in developed nations of the world such as the U.S., Canada. Moreover, it has also stated that there are around 795,000 patient diagnosed with stroke in the U.S. every year where 85% of the total cases were identified as acute ischemic stroke. The National Institute of Health (NIH) stated that healthcare cost for the treatment of stroke exceeds USD 73 billion in the U.S. every year. However, stringent regulatory compliance imposed by the U.S. FDA pertaining to medical device treatment utilized for the human purpose (stroke) is considered as a hurdle for the growth of this market in North America. Europe accounted for the second largest share in the global acute ischemic stroke diagnosis and treatment market in 2013.

Relevant Conferences:

Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 15: Gynecological and Breast Cytopathology

The role of the Cytopathology laboratory in the detection and presumptive identification of microorganisms. Sample procurement by exfoliation, abrasion, and aspiration techniques, as well as a variety of cytopreparatory and staining method. Gynecologic cancers are the uncontrolled growth and spread of abnormal cells originating in the female reproductive organs, including the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva.

Making Strides In Breast Cancer: The most common type of breast cancer is a ductal carcinoma, which begins in the cells of the ducts. Breast cancer can also begin in the cells of the lobules and in other tissues in the breast. Invasive breast cancer is breast cancer that has spread from where it began in the ducts or lobules to surrounding tissue.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 16: Forensic Pathology

All of the disciplines of anatomic and clinical pathology, as well as other forensic sciences, are employed for the solution of medico-legal questions and cases. In the United States, a coroner is typically an elected public official in a particular geographic jurisdiction that investigates and certifies deaths. The vast majority of coroners lack a Doctor of Medicine degree and the amount of medical training that they have received is highly variable, depending on their profession (e.g. law enforcement, judges, funeral directors, emergency medical technicians, nurses).

Forensic statistics is the application of probability models and statistical techniques to scientific evidence, such as DNA evidence, and the law. In contrast to "every day" statistics, to not engender bias or unduly draw conclusions, forensic statisticians report likelihoods as likelihood ratios (LR).

In contrast, a medical examiner is typically a physician who holds the degree of Doctor of Medicine or Doctor of Osteopathic Medicine. Ideally, a medical examiner has completed both a pathology residency and a fellowship in forensic pathology. In some jurisdictions, a medical examiner must be both a doctor and a lawyer, with additional training in forensic pathology.

Relevant Conferences:

Euro Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Cytopathology 2016

2nd International Conference on Cytopathology & Histopathology was organized during August 10-12, 2016 at Las Vegas, USA. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue.


Past Reports  Gallery  

Cytopathology-2015

International Conference on Cytopathology (Cytopathology-2015) was held during August 31-September 02, 2015 at Toronto Airport Marriott Hotel, Canada. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who made this conference fruitful and productive.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 26-27, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
cytopathology@conferenceseries.net
Sponsors / Exhibiting / Advertising.
cytopathology@conferenceseries.com
General Queries.
cytopathology@conferenceseries.net

View Proceedings of Previous Conferences

Cytopathology 2016 Toronto
Pathology 2015
Pathology 2014
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.